Back to Journals » Therapeutics and Clinical Risk Management » Volume 15

Therapeutics and Clinical Risk Management


Archive: Volume 15, 2019

Usefulness of bounce-back admission in monitoring the quality of practice in the emergency department

Tarumi Y, Harada T, Saito T, Hiroshige J, Dohi K

Therapeutics and Clinical Risk Management 2019, 15:647-658

Published Date: 6 May 2019

Rivaroxaban in atrial fibrillation cardioversion: an update

Lavalle C, Straito M, Caroli A, Piro A, Giunta G, Mariani MV, Fedele F

Therapeutics and Clinical Risk Management 2019, 15:613-626

Published Date: 2 May 2019

Pharmacokinetic/pharmacodynamic study of posaconazole delayed-release tablet in a patient with coexisting invasive aspergillosis and mucormycosis

Leelawattanachai P, Montakantikul P, Nosoongnoen W, Chayakulkeeree M

Therapeutics and Clinical Risk Management 2019, 15:589-595

Published Date: 24 April 2019

Frequency of nonaspirin NSAID-relevant coexisting medical conditions in the primary-care setting: a retrospective database review

Bloom L, Boyle KE, Myers AE, Blacketer C, Weinstein R

Therapeutics and Clinical Risk Management 2019, 15:579-588

Published Date: 24 April 2019

Interprofessional safety reporting and review of adverse events and medication errors in critical care

Chapuis C, Chanoine S, Colombet L, Calvino-Gunther S, Tournegros C, Terzi N, Bedouch P, Schwebel C

Therapeutics and Clinical Risk Management 2019, 15:549-556

Published Date: 2 April 2019

Associated factors for depressive disorder in patients with end-stage renal disease treated with continuous ambulatory peritoneal dialysis

Traisathit P, Moolkham K, Maneeton N, Thongsak N, Maneeton B

Therapeutics and Clinical Risk Management 2019, 15:541-548

Published Date: 1 April 2019

Fosfomycin: the characteristics, activity, and use in critical care

Hashemian SMR, Farhadi Z, Farhadi T

Therapeutics and Clinical Risk Management 2019, 15:525-530

Published Date: 27 March 2019

Drug-related problems in patients with rheumatoid arthritis

Ma SN, Zaman Huri H, Yahya F

Therapeutics and Clinical Risk Management 2019, 15:505-524

Published Date: 21 March 2019

Unmet needs in asthma

Gruffydd-Jones K

Therapeutics and Clinical Risk Management 2019, 15:409-421

Published Date: 14 March 2019

Chronic eosinophilic pneumonia: clinical perspectives

Crowe M, Robinson D, Sagar M, Chen L, Ghamande S

Therapeutics and Clinical Risk Management 2019, 15:397-403

Published Date: 13 March 2019

Incidence, clinical features, and risk factors of fluoroquinolone-induced acute liver injury: a case-control study

Yang HY, Guo DH, Jia WP, Zhu M, Xu YJ, Wang XY

Therapeutics and Clinical Risk Management 2019, 15:389-395

Published Date: 8 March 2019

Effects of inhaler therapy on mortality in patients with tuberculous destroyed lung and airflow limitation

Kim HC, Kim TH, Rhee CK, Han M, Oh YM

Therapeutics and Clinical Risk Management 2019, 15:377-387

Published Date: 5 March 2019

Comprehensive evaluation of Manikin-based airway training with second generation supraglottic airway devices

Schmutz A, Bohn E, Spaeth J, Heinrich S

Therapeutics and Clinical Risk Management 2019, 15:367-376

Published Date: 1 March 2019

Adherence to recommended clinical guidelines in extensive disease small-cell lung cancer across the US, Europe, and Japan

DiBonaventura MD, Shah-Manek B, Higginbottom K, Penrod JR, Yuan Y

Therapeutics and Clinical Risk Management 2019, 15:355-366

Published Date: 28 February 2019

Tracheal intubation with the rigid tube for laryngoscopy – a new method

Marchis IF, Radeanu D, Cosgarea M

Therapeutics and Clinical Risk Management 2019, 15:309-313

Published Date: 25 February 2019

Efficacy of denosumab therapy for a 21-year-old woman with Prader-Willi syndrome, osteoporosis and history of fractures: a case report

Uehara M, Nakamura Y, Takahashi J, Suzuki T, Iijima M, Arakawa Y, Ida K, Kosho T, Kato H

Therapeutics and Clinical Risk Management 2019, 15:303-307

Published Date: 25 February 2019

Association of endothelial function with thin-cap fibroatheroma as assessed by optical coherence tomography in patients with acute coronary syndromes

Matsuzawa Y, Hibi K, Saka K, Konishi M, Akiyama E, Nakayama N, Ebina T, Kosuge M, Iwahashi N, Maejima N, Tamura K, Kimura K

Therapeutics and Clinical Risk Management 2019, 15:285-291

Published Date: 15 February 2019

New alternative in the treatment of rheumatoid arthritis: clinical utility of baricitinib

Kawalec P, Śladowska K, Malinowska-Lipień I, Brzostek T, Kózka M

Therapeutics and Clinical Risk Management 2019, 15:275-284

Published Date: 13 February 2019

Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia

Elbedewy TA, Elsebaey MA, Elshweikh SA, Elashry H, Abd-Elsalam S

Therapeutics and Clinical Risk Management 2019, 15:269-274

Published Date: 11 February 2019

Implications from China patient safety incidents reporting system

Gao XQ, Yan SP, Wu WQ, Zhang R, Lu YL, Xiao SY

Therapeutics and Clinical Risk Management 2019, 15:259-267

Published Date: 8 February 2019

Impact of ST-segment elevation on the outcome of Takotsubo syndrome

Gietzen T, El-Battrawy I, Lang S, Zhou X, Behnes M, Ansari U, Borggrefe M, Akin I

Therapeutics and Clinical Risk Management 2019, 15:251-258

Published Date: 7 February 2019

Risk factors of postoperative pulmonary complications after minimally invasive anatomic resection for lung cancer

Yang R, Wu Y, Yao L, Xu J, Zhang S, Du C, Chen F

Therapeutics and Clinical Risk Management 2019, 15:223-231

Published Date: 4 February 2019

Physical function assessment of older adults with lower body fractures at 3 months post-discharge from hospital

Ibrahim NI, Sharkawi Ahmad M, Zulfarina MS, Zaris SNASM, Nor Azlin ZA, Naina Mohamed I, Mohamed N, Mokhtar SA, Shuid AN

Therapeutics and Clinical Risk Management 2019, 15:201-210

Published Date: 29 January 2019

A good first step for ERAS in otolaryngoiatric field, but not enough

Pelli M, Maggi L, Rocco M

Therapeutics and Clinical Risk Management 2019, 15:187-189

Published Date: 25 January 2019

Uterine fibroids: an update on current and emerging medical treatment options

Farris M, Bastianelli C, Rosato E, Brosens I, Benagiano G

Therapeutics and Clinical Risk Management 2019, 15:157-178

Published Date: 23 January 2019

New therapies for the treatment of heart failure: a summary of recent accomplishments

Machaj F, Dembowska E, Rosik J, Szostak B, Mazurek-Mochol M, Pawlik A

Therapeutics and Clinical Risk Management 2019, 15:147-155

Published Date: 22 January 2019

Amiodarone and risk of liver cirrhosis: a nationwide, population-based study

Huang CH, Lai YY, Kuo YJ, Yang SC, Chang YJ, Chang KK, Chen WK

Therapeutics and Clinical Risk Management 2019, 15:103-112

Published Date: 10 January 2019

Incidence rate and risk factors of early repolarization in patients with growth hormone-secreting pituitary adenoma: a cohort study

Chen Z, Hu B, Feng Y, Wang Z, Jiang X, Cheng Y, He D, Zhu D, Xiao Z, Wang H, Mao Z

Therapeutics and Clinical Risk Management 2019, 15:65-72

Published Date: 28 December 2018

Evaluation of medication-related osteonecrosis of the jaw using the Japanese Adverse Drug Event Report database

Inada A, Hosohata K, Oyama S, Niinomi I, Mori Y, Yamaguchi Y, Uchida M, Iwanaga K

Therapeutics and Clinical Risk Management 2019, 15:59-64

Published Date: 24 December 2018

Is correction of segmental kyphosis necessary in single-level anterior cervical fusion surgery? An observational study

Lu J, Sun C, Bai J, Tian S, Zhang B, Tian D, Kong L

Therapeutics and Clinical Risk Management 2019, 15:39-44

Published Date: 19 December 2018

Sex differences in clinical characteristics and 1-year outcomes of young ischemic stroke patients in East China

Geng C, Lin Y, Tang Q, Tang Y, Wang X, Zhou JS, Yang J, Zheng D, Zhang YD

Therapeutics and Clinical Risk Management 2019, 15:33-38

Published Date: 19 December 2018